Concepedia

Publication | Closed Access

Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study

DOI

113

Citations

30

References

2010

Year

Georg Dimcevski, John M. Wo, Per M. Hellström, Lars Christian Gormsen, Irene Sarosiek, Eirik Søfteland, T Nowak, John C. Pezzullo, Laura Shaughnessy, Gordana Kosutic,
Neurogastroenterology & Motility

Abstract

TZP-101 appears to be safe, well-tolerated, and effective at acutely addressing several gastroparesis symptoms.

References

YearCitations

Page 1